Filing Details

Accession Number:
0001140361-11-037820
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-25 12:43:11
Reporting Period:
2011-07-22
Filing Date:
2011-07-25
Accepted Time:
2011-07-25 12:43:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380710 Eric George Davis C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-07-22 3,800 $11.74 43,451 No 4 M Direct
Common Stock Disposition 2011-07-22 3,800 $30.50 39,651 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-07-22 3,800 $0.00 3,800 $11.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
345,800 2006-07-06 2016-01-05 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 7, 2011.
  2. Original option grant 6/48ths on July 6, 2006 and 1/48th on the 6th day of every month thereafter.